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Abstract We have probed the binding of a synthetic peptide
corresponding to the region 550^585 of the K subunit of
dystroglycan with a recombinant protein fragment corresponding
to the N-terminal extracellular region of L-dystroglycan (654^
750), using NMR in solution. In a 30:1 molar ratio, the peptide
binds to the recombinant protein fragment in the fast/inter-
mediate exchange regime. By monitoring the peptide intra-
residue HN^HK peak volumes of the 2D TOCSY NMR spectra,
both in the absence and in the presence of the recombinant
fragment, we determined the differential binding affinities of
each amino acid. We found that the residues in the region 550^
565 (SWVQFNSNSQLMYGLP) are more influenced by the
presence of the protein, whereas the C-terminal portion is
marginally involved. These NMR results have been confirmed by
solid-phase binding assays. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Dystroglycan (DG) is a membrane receptor that provides a
linkage between the cytoskeleton (via dystrophin binding) and
the extracellular matrix (via binding to several proteins and
proteoglycans) [1,2]. It is a member of the dystrophin^glyco-
protein complex (DGC) involved in the maintenance of the
structural integrity of sarcolemma in skeletal muscle ¢bres. In
fact, disruption of the DGC is observed in various forms of
muscular dystrophy [3,4]. DG was found also to play a crucial
role in early development [5]. The receptor is constituted by
two subunits, K and L, which arise from post-translational
cleavage of a single polypeptide chain [1]. L-DG, which con-
tains the transmembrane domain, interacts with dystrophin
and dystrophin-related proteins inside the cytoplasm, whereas
K-DG, the highly glycosylated peripheral membrane subunit,
binds extracellular matrix proteins containing laminin-type
LG domains [6^8]. It is likely that DG also plays a role as
a signal transduction protein [9].
Although many biological studies have been devoted to the
elucidation of the role of DG in both development and disease
[2], very few structural studies have been reported [10]. In fact,
the large size of DG (895 amino acids, K-DG = 1^653 and L-
DG = 654^895), its high level of glycosylation and its mem-
brane-bound nature make this protein an extremely challeng-
ing system using classical structural methods (X-ray and nu-
clear magnetic resonance (NMR)).
One successful approach has been to dissect this large com-
plex and to study the di¡erent subdomains as separate inde-
pendent entities [11^13]. Using a full series of recombinant
fragments and solid-phase binding assays, we found that a
region as short as 36 amino acids (550^585) of the K subunit
is crucial for interactions with the L subunit (Sciandra,
Schneider, Giardina, Baumgartner, Petrucci and Brancaccio,
submitted).
In this study, using NMR spectroscopy we have investi-
gated the binding of a synthetic K-DG peptide (550^585) to
the recombinant protein fragment corresponding to the entire
N-terminal extracellular region of L-DG (654^750) and iden-
ti¢ed the amino acids responsible for the interaction.
2. Materials and methods
2.1. Recombinant proteins and synthetic peptide
Standard polymerase chain reaction (PCR) protocols were used
to amplify the DNA constructs required for the production of
the recombinant dystroglycan fragments under analysis. L-DG(654^
750) and K-DG(485^651) were prepared as described elsewhere
[13]. To prepare the three deleted K-DG fragments, K-DGC(485^
585), K-DGC(485^572) and K-DGC(485^550), the same forward
primer, 5P-CCCGTCGACAGTGGAGTGCCCCGTGGGGGAGAA-
C-3P (SalI restriction site in bold and target sequence underlined) was
used together with di¡erent 3P primers, respectively: 5P-CCCGAA-
TTCTTAGAGGCCCCCTTTGTCTGTGGCATGC-3P for K-DGC-
(485^585), 5P-CCCGAATTCTTATTTTCCCACATGGCTGCTGTC-
AGGC-3P for K-DGC(485^572), and 5P-CCCGAATTCTTACGA-
TTTCTCACCTACTAACTGCTGC-3P for K-DGC(485^550) (EcoRI
restriction site in bold and target sequences underlined). The recombi-
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nant proteins were expressed in Escherichia coli BL21(DE3) cells and
puri¢ed as described elsewhere [12,13]. The synthetic peptide
K-DGC(550^585) was purchased from Synt:em and further puri¢ed
using HPLC chromatography. The puri¢ed peptide was dissolved in a
solution (90% H2O and 10% D2O) containing 0.05% acetate bu¡er
and the pH was adjusted to a ¢nal value of V4.0.
2.2. Solid-phase binding assays
Recombinant L-DG(654^750) was biotinylated as described else-
where [13]. To assess the binding properties of recombinant K-DG
proteins to L-DG(654^750), solid-phase assays were performed as fol-
lows: 0.1^0.5 Wg/well of each recombinant protein was immobilised on
microtitre plates by overnight incubation at 4‡C in coating bu¡er
(50 mM NaHCO3 pH 9.6). The plates were washed three times with
Tris-bu¡ered saline (TBS), 0.05% Tween-20 (T-TBS), containing
1.25 mM CaCl2 and 1 mM MgCl2 (wash bu¡er), and then incubated
for 1 h in T-TBS containing 3% milk powder for blocking unspeci¢c
binding sites. After extensive washing with wash bu¡er, wells were
incubated with biotinylated L-DG(654^750) in T-TBS, 1% bovine se-
rum albumin (BSA), 1% milk powder, 1.25 mM CaCl2 and 1 mM
MgCl2 for 3 h at room temperature. The biotinylated L-DG(654^750)
bound fraction was detected with the Vectastain AB complex from
Vector Laboratories (Burlingame, CA, USA). 5 mg of p-nitrophenyl
phosphate in 10 ml of 10 mM diethanolamine and 0.5 mM MgCl2 was
used as substrate for the alkaline phosphatase and quantitative mea-
surements were carried out at 405 nm. The absorbance values were
corrected for the signals obtained incubating biotinylated L-DG(654^
750) only with BSA (V0.5 Wg/well). Data were ¢tted using a hyper-
bolic model for a single class of binding sites according to the equa-
tion: ODi = ODtotUc/(Kd+c), where ODi represents the absorbance
measured at increasing concentrations of ligands, Kd is the binding
dissociation constant, c is the concentration of biotinylated
L-DG(654^750), and ODtot the absorbance at saturation. Data were
normalised according to the equation: ODi/ODtot and are reported as
fractional saturation (%).
2.3. NMR experiments
All NMR experiments were run on Varian Unity Plus 600 and
800 MHz spectrometers equipped with a triple-resonance probe and
a triple-axis gradient unit. The temperature was held constant at
298 K. The proton assignments of the K-DGC(550^585) peptide
were obtained with a series of TOCSY and NOESY experiments
[14]. The number of scans was 32 for 512 data points in the indirect
dimension. The mixing times ranged from 40 to 70 ms for the TOCSY
spectra and from 200 to 250 ms for NOESY spectra. The concentra-
tion of K-DGC(550^585) peptide was V1 mM and a 1:30
[L-DG(654^750)]:[peptide] ratio was used. The spectra were recorded
with spectral widths of 7000 Hz and 9000 Hz on the 600 MHz and
800 MHz spectrometers, respectively. Water suppression was achieved
using WATERGATE [15] pulse sequence. Data were processed using
NMRPIPE [16] and the peak volumes were calculated using a Gaus-
sian ¢t enclosed in the Sparky software package (http://www.cgl.
ucsf.edu/home/sparky/).
3. Results
The primary sequence of the synthetic peptide spanning the
amino acid sequence 550^585 of the C-terminal domain of
vertebrate K-DG is reported in Table 1 together with the
complete resonance assignment, which was accomplished us-
ing 1H/1H NOESY and TOCSY experiments [14]. In the ab-
sence of the L-DG(654^750) fragment, the amide region of the
peptide displays sharp and poorly dispersed resonances typical
of random coil conformation (see Fig. 1A). Further, the 1H/
1H NOESY spectra show only the presence of sequential
NOEs in both aliphatic and amide regions (data not shown).
From these observations, we conclude that in the absence of
the L-DG(654^750) fragment, the peptide is mostly unstruc-
tured in aqueous solution. Upon titration with increasing
amounts of L-DG(654^750), we observed a general broaden-
ing of the peptide resonances (Fig. 1B,C,E,F), indicating that
the peptide assumes the correlation time of the L-DG(654^
750). From a closer analysis of the 1D 1H spectra of the
peptide amide and aromatic region, it becomes clear that
the peptide interacts with the protein at a ratio of 100:1,
Fig. 1. 1D spectra of 1 mM synthetic K-DGC(550^585) in sodium
acetate bu¡er 0.05%, pH 4.0, at 25‡C showing line broadening
e¡ects in the amide (A^C) and aromatic (D^F) regions. Peaks refer-
ring to Trp551 and Val552 are indicated by arrows. Di¡erent
[K-DGC(550^585)]:[L-DG(654^750)] ratios are reported: (A, D)
K-DGC(550^585) in the absence of L-DG(654^750), (B, E) 100:1,
(C, F) 30:1.
Table 1
Proton NMR assignments for K-DG(550^585) in H2O:D2O (90:10)
at pH 4.0 and 25‡C
Residue NH KH LH Others
S550 8.21 4.14
W551 8.65 4.75 3.27, 3.23 2H 7.22, 4H 7.59, 5H 7.11, 6H
7.21, 7H 7.46, NH 10.10
V552 7.91 3.92 1.84 QCH3 0.78, 0.74
Q553 8.12 4.08 1.89, 1.83 QCH2 2.18, 2.14, NNH2 7.43,
6.84
F554 8.20 4.57 3.08, 2.99 2,6H 7.20, 4H 7.26, 3,5H 7.30
N555 8.32 4.66 2.77, 2.65 QNH2 7.52, 6.86
S556 8.36 4.37 3.92
N557 8.44 4.74 2.86, 2.79 QNH2 7.57, 6.91
S558 8.20 4.32 3.90, 3.85
Q559 8.29 4.27 2.11, 1.98 QCH2 2.34, NNH2 7.47, 6.83
L560 8.01 4.24 1.59 QCH1.48, NCH3 0.89, 0.82
M561 8.10 4.36 1.92, 188 QCH2 2.40, 2.33
Y562 8.03 4.54 3.09, 2.90 2,6H 7.09, 3,5H 6.79
G563 8.16 3.87
L564 7.99 4.60 1.62, 1.58 QCH 1.55, NCH3 0.93
P565 4.07 2.25, 2.00 QCH2 1.89, NCH2 3.63
D566 8.40 4.58
S567 8.32 4.34 3.95, 3.85
S568 8.28 4.32 3.83
H569 8.31 4.71 3.29, 3.13 2H 8.55, 4H 7.25
V570 7.97 4.09 2.07 QCH3 0.93
G571 8.50 3.92
K572 8.13 4.27 1.76, 1.67 QCH2 1.39, 1.32, NCH2 1.63,
OCH2 2.96
H573 8.56 4.58 3.12, 3.08 2H 8.55, 4H 7.12
E574 8.37 4.23 1.87, 1.81 QCH2 2.24, 2.18
Y575 8.19 4.46 2.91, 2.83 2,6H 7.02, 3,5H 6.75
F576 8.04 4.55 3.05, 2.92 2,6H 7.17, 4H 7.25, 3,5H 7.29
M577 8.16 4.32 1.95, 1.89 QCH2 2.44, 2.39
H578 8.37 4.66 3.27, 3.14 2H 8.59, 4H 7.28
A579 8.42 4.35 1.40
T580 8.17 4.33 4.24 QCH3 1.19
D581 8.30 4.61 2.80, 2.77
K582 8.34 4.28 1.89, 1.75 QCH2 1.46, 1.40, NCH2 1.67,
OCH2 2.98
G583 8.42 3.94
G584 8.23 3.94
L585 8.13 4.30 1.67, 1.59 NCH3 0.92, 0.86
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showing a high a⁄nity for the extracellular fragment of
L-DG(654^750) (see Fig. 1B,E), and that some of the residues
are more involved in the binding than others as shown by the
di¡erential broadening of the amide and aromatic signals. In
Fig. 1C,F, where the molar ratio [peptide] :[protein] is 30:1,
one can see that the isolated peak of Trp551 is particularly
in£uenced by the presence of the protein, whereas other res-
onances appear to be very sharp. At [peptide] :[protein] molar
ratios lower than 20:1, the peptide resonances become unde-
tectably broad (data not shown). Based on these results, the
30:1 [peptide] :[protein] molar ratio was chosen as the best
ratio at which to reveal the di¡erential broadening of the lines
and to carry out all our 2D TOCSY experiments. Under these
conditions, we can determine which amino acids are respon-
sible for the binding using di¡erential line broadening [17^19].
We found that the presence of L-DG(654^750) signi¢cantly
in£uences the peptide TOCSY spectrum in the ¢ngerprint
region (Fig. 2A,B). A general broadening of the crosspeaks
is observed, but some di¡erential e¡ects are remarkable, in-
dicating that a number of residues belonging to synthetic pep-
tide K-DGC(550^585) interact preferentially with L-DG(654^
750). This can be observed in particular for residues Trp551,
Val552, Gln553, Asn555, Gln559, Leu560, Met561 and Gly563. The
di¡erential broadening is illustrated in more detail in Fig. 3
where two selected crosspeaks of the TOCSY spectra and
their slices, referring to Gln553 and Val570, show very di¡erent
intensity ratios upon addition of L-DG(654^750), suggesting
that Gln553 participates more in the binding with L-DG(654^
750) than Val570.
In order to determine if changes in peptide backbone con-
formation are induced by L-DG(654^750), we also performed
transfer NOESY experiments (data not shown). Although the
interpretation of these experiments was limited by the spectral
overlap of several connectivities, more intense transfer NOEs
than their corresponding NOEs were observed. It is likely that
these e¡ects are due to the increased correlation time associ-
ated with the peptide/L-DG(654^750) complex resulting in
more e⁄cient cross-relaxation between proton pairs in prox-
imity. However, the small number of new connectivities in-
duced by L-DG(654^750) suggests that the peptide backbone
conformation is still substantially unstructured in the bound
form.
We evaluated the extent of binding for each amino acid
calculating the ratio Vfree/Vbound, where Vfree is the volume
of the intra-residue HN^HK crosspeak of the 2D TOCSY
spectrum in the absence of L-DG(654^750) and Vbound is the
volume of the same crosspeak in the presence of L-DG(654^
750). A plot summarising all the Vfree/Vbound ratios versus
residue numbers for all the amino acids is shown in Fig. 4.
Although all the resonances are in£uenced by the interaction
with L-DG(654^750), the interaction of the N-terminus of the
Fig. 2. 2D TOCSY spectra in the ¢ngerprint region of 1 mM
synthetic K-DGC(550^585) in sodium acetate bu¡er 0.05%, pH 4.0,
at 25‡C in the absence (A) and in the presence (B) of 30 WM
L-DG(654^750).
Fig. 3. Selected region of the TOCSY spectra of 1 mM synthetic
K-DGC(550^585) in sodium acetate bu¡er 0.05%, pH 4.0, at 25‡C,
in the absence (A) and in the presence (B) of L-DG(654^750) 30 WM
(bottom). At the top of the ¢gure are shown the slices of the same
crosspeaks. A part of the drastic loss of signal to noise ratio from
A to B, a signi¢cant di¡erence in the relative intensity of the reso-
nances is clearly observed.
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synthetic peptide is more pronounced, while that of the
C-terminal portion is only marginally involved.
The Vfree/Vbound ratios measured in a decreasing order are:
Asn555, Gln553, Ser556, Gly563, Met561, Gln559, which all belong
to the N-terminal portion (550^565, see Fig. 5A). In addition,
Val552, Glu574 and Trp551 also show values over the average
(Fig. 4).
In order to validate the results obtained by NMR experi-
ments, we carried out solid-phase binding assays using a new
recombinant fragment belonging to the C-terminal region of
K-DG, K-DGC(485^572), which includes the N-terminal por-
tion of the 550^585 sequence. K-DGC(485^651), K-DGC(485^
585) and K-DGC(485^550) were used as a control (Fig. 5A).
Although the Kd values should be considered as apparent,
solid-phase binding assays are frequently used to collect qual-
itative or semi-quantitative reliable estimates on the a⁄nity of
interaction between two proteins [20]. We found that
K-DGC(485^572) binds to L-DG(654^750) with high a⁄nity
(Kd = 6 þ 1 WM) and in a similar fashion as K-DGC(485^651)
(Kd = 6 þ 2 WM), which corresponds to the entire K-DG C-
terminal domain, and K-DGC(485^585) (Kd = 12 þ 2 WM),
whereas K-DGC(485^550) shows no detectable a⁄nity (Fig.
5B).
4. Discussion
DG is a receptor formed by an extracellular subunit, K-DG,
and a transmembrane one, L-DG, that interact tightly but
non-covalently. In a previous work, we found that the binding
epitope for L-DG is located within the C-terminal domain of
K-DG and that the binding is independent of glycosylation
[13]. Recently, using a progressive deletion recombinant ap-
proach, the binding epitope has been further narrowed down
to a sequence as short as 36 amino acids (550^585) (Sciandra,
Schneider, Giardina, Baumgartner, Petrucci and Brancaccio,
submitted). We have used an NMR approach to investigate in
more detail the binding between a synthetic peptide corre-
sponding to the 550^585 sequence of vertebrate K-DG and
the recombinant fragment L-DG(654^750), which corresponds
to the N-terminal extracellular region of L-DG.
It has been shown that the recombinant L-DG(654^750)
fragment is mainly unstructured in aqueous solution, with
short stretches of secondary structure [21]. Although we can-
not rule out the oligomerisation or the formation of aggre-
gates at higher concentrations (s 200 WM [21]), we carried out
NMR experiments at a relatively low concentration of
L-DG(654^750) (V30 WM), which makes the aforementioned
phenomena unlikely. However, it is clear that the plasticity of
L-DG(654^750) makes it very di⁄cult to obtain workable
NMR data. In spite of these di⁄culties, NMR methods can
be a great tool for obtaining atomic resolution of protein^
protein interactions without determining entire protein struc-
tures [22]. The binding properties of the molecules can be
probed in several ways, depending on the kinetics of the bind-
ing. When the time regime of the interaction is fast on the
NMR time scale, binding sites can be detected using di¡er-
ences in chemical shifts, while in studies with small ligands
bound to macromolecules, the ratios between selective and
non-selective relaxation rates can be analysed ([23] and refer-
ences therein). With fast/intermediate exchange a linewidth
broadening is observed. Di¡erential line broadening can be
Fig. 4. Plot of the ratios Vbound/Vfree normalised with respect to the
maximum values, versus the amino acidic sequence of K-DGC(550^
585). The horizontal bar represents the average ratio.
Fig. 5. A: The C-terminal region of K-DGC is extended from amino
acid 485 to 653. This region harbours the binding epitope (550^585)
for the extracellular domain of L-DG(654^750). The K-DGC(485^
651) fragment that corresponds to almost the entire K-DG C-termi-
nal region has been used as a control, together with K-DGC(485^
585) and K-DGC(485^550) [13]. B: Solid-phase binding assays, using
biotinylated L-DG(654^750) as a ligand, were performed to test the
K-DG recombinant fragments’ binding properties. The fragments
K-DGC(485^651) (P), K-DGC(485^572) (b) and K-DGC(485^585)
(E) show a similar binding activity (Kd = 6 þ 2 WM, Kd = 6 þ 1 WM
and Kd = 12 þ 2 WM respectively), whereas fragment K-DGC(485^
550) (F) does not bind the extracellular region of L-DG in the con-
centration range analysed. Data refer to representative experiments.
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used to determine the residues directly involved in the binding
[17^19]. Thus, the line shapes, or simply the ratios of the peak
volumes of peptide in the bound and in the free states, can
give a direct estimation of the extent of the involvement of
each single amino acid in the binding process.
In this case, assuming that the Kd for the peptide/protein
complex is V6 WM and that the rate of peptide association
with L-DG(654^750) is di¡usion-limited (108 M31 s31), it can
be estimated that the upper limit for the o¡ rate is about
6U102 s31, which is in the range of the intermediate exchange
[24,25]. In such a regime of exchange, the broadening of some
NH might be due to the averaging of bound resonances which
experience large chemical shift changes. A di¡erential line
broadening may also result from the di¡erent overall correla-
tion time that the peptide assumes when bound to L-DG(654^
750).
We were able to demonstrate via 1D and 2D TOCSY ex-
periments (Figs. 1^4) that (i) the synthetic peptide binds to
L-DG also in solution, (ii) its N-terminal portion (550^565) is
preferentially involved in the binding, as con¢rmed by solid-
phase analysis (Fig. 5), and (iii) residues Asn555, Gln553,
Ser556, Gly563, Met561 and Gln559 are those more likely to
interact with L-DG.
By combining NMR methods and solid-phase binding as-
says, we have identi¢ed ‘hot spots’ within the K/L-DG binding
surface. As for other protein^protein interactions [26], we
found that the binding is con¢ned to a discrete subset of
only 16 residues, 550SWVQFNSNSQLMYGLP565. In fact,
the presence of the peptide corresponding to K-DG(485^572)
(Fig. 5) is su⁄cient for the interaction with L-DG(654^750) to
take place. Even though Glu574 is the only residue within the
C-terminal portion of the 550^585 sequence to show some
interaction (Fig. 4), its presence is not a requirement for the
interaction to take place, as demonstrated by the binding
behaviour of K-DGC(485^572) (Fig. 5B).
Our research gives valuable molecular insight into the di-
merisation interface of DG and paves the way for further
studies employing site-directed mutagenesis, to elucidate the
contribution of each single amino acid to the interaction. To
investigate details of the local conformation of the bound
form of the peptide, we are currently carrying out experiments
on a shorter K-DGC peptide and trying to prepare an isotope-
labelled L-DG(654^750).
A detailed understanding of the interaction between K- and
L-DG at the molecular level would facilitate the rational de-
sign of drugs aimed to modulating the function of the DG
receptor molecule. For example, a speci¢c inhibitory agent
could be used to inactivate this receptor for arenaviruses or
Mycobacterium leprae infections [27,28] or to strengthen the
interactions between the DG subunits in all those severe mus-
cular dystrophies in which the receptor is either absent or
reduced within the sarcolemma [2].
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